AI assistant
EVRAZ PLC — Director's Dealing 2019
Mar 28, 2019
5304_dirs_2019-03-28_1ef086de-3bd1-4f9e-8030-8fafc125dd96.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2902U
Evraz Plc
28 March 2019
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
EVRAZ plc (or "the Company") reports that on 27 March 2019 Mr. Nikolay Ivanov, a person discharging managerial responsibility in EVRAZ plc, has sold the 70,000 EVRAZ plc Ordinary Shares.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Nikolay Ivanov
2
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EVRAZ plc
b)
LEI
5493005B7DAN39RXLK23
4
Details of the transaction(s):
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares
GB00B71N6K86
b)
Nature of the transaction
Sale of shares.
c)
Price(s) and volume(s)
| Date/time | Price | Volume | Amount | |
| (a) | 2019-03-27 13:46:13 UK |
£6.084721 | 70,000 | £425,930.47 |
| (b) | ||||
| (c) | ||||
| 70,000 | £425,930.47 |
d)
Aggregated information
-Aggregated volume
-Price
e)
Date/time of the transactions
f)
Place of the transaction
London Stock Exchange (XLON)
EVRAZ Investor Relations
+7 495 232 1370
28 March 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHZVLBLKXFBBBX